Abstract
Virucidal activity of Povidone-Iodine (PVP-I) have not yet been performed specifically on SARS-CoV-2. There have been in vitro studies demonstrating its effectiveness against multiple viruses including related coronaviruses. PVP-I could be effective to reduce viral load from asymptomatic COVID-19 patients and also provide a protective oropharyngeal hygiene measure for the health professionals.
Original language | English |
---|---|
Pages (from-to) | 1-2 |
Number of pages | 2 |
Journal | Electronic Journal of General Medicine |
Volume | 18 |
DOIs | |
Publication status | Published - 2021 |
Keywords
- COVID-19
- Coronavirus
- Oral health
- Risk management